Complications of crotalidae antivenin therapy

Gregory Jurkovich, Arnold Luterman, Keith Mc Cullar, Max L. Ramenofsky, P. William Curreri

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Polyvalent antivenin is the mainstay of treatment of serious snake envenomation. Its use, however, has been challenged as being unnecessary in minor envenomations and potentially hazardous due to allergic complications. Our institution routinely uses antivenin, and this report focuses on the allergic complications of this therapy. Forty patients with Crotalidae snake bites were evaluated and treated over a 7-year period. Twenty-six patients received a total of 507 vials of antivenin, the dose correlating with the clinical severity of envenomation. All patients were skin tested. Immediate hypersensitivity reactions occurred in six patients (23%). Cutaneous manifestations alone occurred in three of these patients, while systemic anaphylaxis occurred in three. Twenty patients were available for followup, and ten (50%) developed serum sickness. Skin testing was not reliable in predicting the development of immediate (anaphylaxis) or delayed (serum sickness) hypersensitivity reactions. Treatment of antivenin allergic reactions was uniformly effective, with no mortality, minimal morbidity, and no chronic sequelae.

Original languageEnglish (US)
Pages (from-to)1032-1037
Number of pages6
JournalJournal of Trauma - Injury, Infection and Critical Care
Volume28
Issue number7
DOIs
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Antivenins
Serum Sickness
Snake Bites
Anaphylaxis
Hypersensitivity
Therapeutics
Skin Manifestations
Immediate Hypersensitivity
Skin
Morbidity
Mortality

ASJC Scopus subject areas

  • Surgery
  • Critical Care and Intensive Care Medicine

Cite this

Complications of crotalidae antivenin therapy. / Jurkovich, Gregory; Luterman, Arnold; Mc Cullar, Keith; Ramenofsky, Max L.; Curreri, P. William.

In: Journal of Trauma - Injury, Infection and Critical Care, Vol. 28, No. 7, 01.01.1988, p. 1032-1037.

Research output: Contribution to journalArticle

Jurkovich, Gregory ; Luterman, Arnold ; Mc Cullar, Keith ; Ramenofsky, Max L. ; Curreri, P. William. / Complications of crotalidae antivenin therapy. In: Journal of Trauma - Injury, Infection and Critical Care. 1988 ; Vol. 28, No. 7. pp. 1032-1037.
@article{cd018aa8ce8c4bcd9601275f73d27c88,
title = "Complications of crotalidae antivenin therapy",
abstract = "Polyvalent antivenin is the mainstay of treatment of serious snake envenomation. Its use, however, has been challenged as being unnecessary in minor envenomations and potentially hazardous due to allergic complications. Our institution routinely uses antivenin, and this report focuses on the allergic complications of this therapy. Forty patients with Crotalidae snake bites were evaluated and treated over a 7-year period. Twenty-six patients received a total of 507 vials of antivenin, the dose correlating with the clinical severity of envenomation. All patients were skin tested. Immediate hypersensitivity reactions occurred in six patients (23{\%}). Cutaneous manifestations alone occurred in three of these patients, while systemic anaphylaxis occurred in three. Twenty patients were available for followup, and ten (50{\%}) developed serum sickness. Skin testing was not reliable in predicting the development of immediate (anaphylaxis) or delayed (serum sickness) hypersensitivity reactions. Treatment of antivenin allergic reactions was uniformly effective, with no mortality, minimal morbidity, and no chronic sequelae.",
author = "Gregory Jurkovich and Arnold Luterman and {Mc Cullar}, Keith and Ramenofsky, {Max L.} and Curreri, {P. William}",
year = "1988",
month = "1",
day = "1",
doi = "10.1097/00005373-198807000-00020",
language = "English (US)",
volume = "28",
pages = "1032--1037",
journal = "Journal of Trauma and Acute Care Surgery",
issn = "2163-0755",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Complications of crotalidae antivenin therapy

AU - Jurkovich, Gregory

AU - Luterman, Arnold

AU - Mc Cullar, Keith

AU - Ramenofsky, Max L.

AU - Curreri, P. William

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Polyvalent antivenin is the mainstay of treatment of serious snake envenomation. Its use, however, has been challenged as being unnecessary in minor envenomations and potentially hazardous due to allergic complications. Our institution routinely uses antivenin, and this report focuses on the allergic complications of this therapy. Forty patients with Crotalidae snake bites were evaluated and treated over a 7-year period. Twenty-six patients received a total of 507 vials of antivenin, the dose correlating with the clinical severity of envenomation. All patients were skin tested. Immediate hypersensitivity reactions occurred in six patients (23%). Cutaneous manifestations alone occurred in three of these patients, while systemic anaphylaxis occurred in three. Twenty patients were available for followup, and ten (50%) developed serum sickness. Skin testing was not reliable in predicting the development of immediate (anaphylaxis) or delayed (serum sickness) hypersensitivity reactions. Treatment of antivenin allergic reactions was uniformly effective, with no mortality, minimal morbidity, and no chronic sequelae.

AB - Polyvalent antivenin is the mainstay of treatment of serious snake envenomation. Its use, however, has been challenged as being unnecessary in minor envenomations and potentially hazardous due to allergic complications. Our institution routinely uses antivenin, and this report focuses on the allergic complications of this therapy. Forty patients with Crotalidae snake bites were evaluated and treated over a 7-year period. Twenty-six patients received a total of 507 vials of antivenin, the dose correlating with the clinical severity of envenomation. All patients were skin tested. Immediate hypersensitivity reactions occurred in six patients (23%). Cutaneous manifestations alone occurred in three of these patients, while systemic anaphylaxis occurred in three. Twenty patients were available for followup, and ten (50%) developed serum sickness. Skin testing was not reliable in predicting the development of immediate (anaphylaxis) or delayed (serum sickness) hypersensitivity reactions. Treatment of antivenin allergic reactions was uniformly effective, with no mortality, minimal morbidity, and no chronic sequelae.

UR - http://www.scopus.com/inward/record.url?scp=0023783732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023783732&partnerID=8YFLogxK

U2 - 10.1097/00005373-198807000-00020

DO - 10.1097/00005373-198807000-00020

M3 - Article

C2 - 2899649

AN - SCOPUS:0023783732

VL - 28

SP - 1032

EP - 1037

JO - Journal of Trauma and Acute Care Surgery

JF - Journal of Trauma and Acute Care Surgery

SN - 2163-0755

IS - 7

ER -